Shaping the Future of Human Health
Innovation is the lifeblood of medical advancement.
This is what we believe. This is what drives us.
What We Do
Our mission is to advance human health worldwide by forging stronger alliances among innovators, industry and government.
Why We Do It
We are invested in making a meaningful difference in the lives of patients and their families around the globe.
We like to think our headquarters are in Silicon Valley, but our home is the world. We are a global hub for novel thinking and creation. Providing a bold model for shaping the future of human health, guided by a focused, comprehensive vision.
As a nonprofit in the medical technology space, we are unique by nature. And we’ve leveraged our distinctive status to create an unmatched environment, where medtech community stakeholders converge to transform healthcare. Together, innovating visionary approaches to address unmet needs.
The cultivation of medical technology companies at various stages of development is at the heart of Fogarty Innovation’s mission, and the core of our history. From day one, we have teamed with medtech pioneers through our tailored incubation and acceleration programs. Get to know some of our current entrepreneurs and the groundbreaking ideas we are helping them translate into game-changing solutions for patients worldwide.
Autoimmune diseases are the third most common category of disease in the United States, affecting up to 27 million people. Boomerang Medical is a bioelectronic medicine company developing technology to advance the treatment of autoimmune diseases by harnessing the body’s own “peripheral wiring” in order to manage inflammation and immune response. Boomerang Medical is backed by Arboretum Ventures, a venture capital firm specializing in companies that improve patient outcomes and reduce healthcare system costs.
While many of our vital signs are easily obtained, the one test that doctors rely on to make the majority of their diagnoses—the blood test—can take hours, if not days, for results. Chronus Health has developed a portable device that provides lab results in minutes, allowing for real-time diagnosis and promising to dramatically improve time-to-care and patient outcomes. The startup has focused its initial efforts on complete blood count (CBC) and comprehensive metabolic panel (CMP), which account for 50 percent of all blood tests performed in the United States.
Current chronic therapies for short bowel syndrome (SBS), a malabsorption disorder caused by the lack of a functional small intestine, include expensive medication and intestinal surgery. These approaches have low success rates and a staggering average 5-year cost of care of $1.6 million per patient. Eclipse Regenesis is developing the first restorative therapy for pediatric and adult SBS patients with the Eclipse XL1 Distraction Enterogenesis System, which harnesses the body’s own tissue regenerative capabilities to produce new, fully functional intestine.
Skin cancer is the most common form of malignancy, with more individuals diagnosed each year than for all other cancers combined. For the last 150 years, these malignancies have required an invasive biopsy for diagnosis, but Enspectra is leading a digital transformation in pathology by imaging real-time cellular anatomy in living tissue, without cuts or stains.
As the adoption of telehealth increases, on-demand testing is no longer confined to healthcare settings. Everyplace is aiming to turn any location into a point-of-care lab with a self-service diagnostic kiosk that enables patient-initiated testing in community-based settings. It is designing simple, reliable, contactless patient-initiated testing to facilitate on-demand diagnostics as a complement to telehealth across a range of routine tests.
More than 110 million people worldwide suffer from non-healing, open wounds. High costs and overly complex technology severely limit, or even preclude, access to advanced wound care technology. Healyx Labs is developing the lowest-cost and easiest-to-use wound vacuum technology for price-sensitive and underserved markets.
One hundred seventy-eight million adults in the United States are missing at least one tooth, and a surprising 40 million are missing all their teeth. Dental implants are the top treatment choice of treatment, but this solution is utilized by less than 2 percent of those impacted by tooth loss because of limited accessibility, high cost, high risk and long treatment time. iDentical is leveraging the latest 3D technology to offer a safer, faster and more affordable solution through its drill-free, non-invasive dental implants.
Approximately 50 percent of all women in the U.S. will suffer symptoms of a pelvic floor disorder resulting from childbirth by the time they turn 55, and over 20 million suffer from pelvic pain. Materna has developed an obstetrics and gynecology platform of medical devices: the first, Prep, is aimed at preventing maternal pelvic injuries during childbirth and shortening delivery time; the second, Milli, is helping treat pelvic pain and dyspareunia.
More than 36 million patients in the U.S. suffer from chronic rhinosinusitis. The condition accounts for 1 to 2% of all physician visits and is associated with $7 to 12 billion in direct U.S. healthcare costs per year. Nasal steroid sprays are typically prescribed as standard of care, but are only partially effective as they cannot reach beyond the anterior portion of the nasal cavity. Nasus Medical is developing solutions for improved intra-nasal drug delivery through an innovative technology that is designed for patients to treat themselves at home, early in the pathway.
Ultrasound is a key tool for diagnosing potentially life-threatening problems, but patients too often die before they reach a facility. UltraSight facilitates point-of-care ultrasound in the cardiac imaging space by offering real-time on-screen guidance and quality assessment using a layer of intelligence that simplifies and standardizes ultrasound cardiac scanning.
Our Guiding Principles
Who We Work With
The medical technology ecosystem is shaped by a variety of interconnected constituents—private and public, financial and philanthropic, academic and industrial. Our years of experience in this dynamic space have helped us build relationships with many of these stakeholders and understand their unique viewpoints and interests. With this as a foundation, we are able to facilitate collaborations and synergies that help innovative solutions reach patient care and advance human health worldwide.
– Venture Capitalist
The growing list of groups with whom we are proud to actively collaborate includes:
Medtech Advocacy Groups
Other Global Innovation Programs
The Investment Community
Developing healthcare solutions for a diverse population requires innovation teams fueled by diverse viewpoints, backgrounds, opinions, and experiences. To improve diversity in the health technology innovation ecosystem, we teamed up with Stanford Biodesign to found and support Diversity by Doing Healthtech. Learn more about DxD as well as our partnerships with other organizations dedicated to diversity.
Join Our Journey
We are all innovators and have something novel to bring to life—whether that is an innovative idea, a new technology, or simply the conviction that there must be a better way. If healthcare is your passion—and you’re driven to shape its future—we encourage you to learn more about Fogarty Innovation’s audacious vision. Join us as we seek to inspire innovation and make a difference in the medical technology ecosystem. Help us turn possibilities into realities. Please read on and contact us to begin your journey.
Latest Blogs and Videos
Stanford Byers Center for Biodesign’s most recent From the Innovator’s Workbench event on April 13 featured the prominent entrepreneur Anne Wojcicki, co-founder and CEO of...
Fogarty Innovation’s newest staff member, Allie Gregorian, has spent nearly two decades in leadership and advocacy roles in academic medicine and the nonprofit sector. Allie has...
When an employee on the job feels the onset of flu or COVID symptoms, their first step is usually to make a doctor’s appointment. By the time they visit a clinic and receive...